HydrationBarrierFirmnessRenewal

Companion tools for your GLP-1 journey

From hydration and barrier repair to firmness and renewal, Karespot’s free tools and companion skin-care cover the adjacent needs your skin faces on a GLP-1 journey, so your face keeps up with your progress.

Why does your skin change on a GLP-1 journey?

GLP-1 medications can produce weight loss of roughly 15 to 20% of body weight, far faster than most lifestyle-only approaches.12 When subcutaneous fat leaves the face quickly, the skin above it does not always have time to remodel and retract. The result many people describe as “GLP-1 face”: hollowed cheeks and temples, deeper folds, and looser skin along the jaw.

Two more factors compound this. Reduced appetite, the quieting of food noise, often lowers protein and micronutrient intake, the raw materials skin needs for collagen and elastin. And eating and drinking less can leave skin mildly dehydrated, so it looks thinner and more lined. Your skin deserves a plan of its own, running alongside your weight-loss plan.

How rapid facial fat loss can show on the skin

What actually helps

Steady paceProtein & strengthHydrationSun protectionBarrier care

These levers keep skin resilient while it adapts.23 A gradual dose ramp helps too, so it is worth knowing how GLP-1 doses step up over time. Barrier care is why we formulated the GLP-Kare Companion Moisturiser, and our Kare-Hub covers the full routine.

How the free risk assessment works

1

Answer 2 minutes of questions

Your medication, pace of weight loss, age, hydration, protein intake, sun habits and current skin care.

2

Get your risk score

A clear, personalised score for facial volume loss and skin laxity, no login needed to start.

3

Receive your skin plan

Practical, prioritised steps you can start the same day, matched to your risk profile.

More from the Kare-Hub

Guidance from the Karespot medical team on getting the most from your GLP-1 journey:

GLP-1 & your skin

GLP-1 skin questions, answered

What is 'GLP-1 face'?

'GLP-1 face' is a cosmetic term for the hollow, gaunt, prematurely aged look that can follow rapid GLP-1 weight loss. When facial fat is lost faster than skin can retract, the face can look deflated, with more visible folds and laxity. It is a change in skin and facial structure, not a medical condition.

Yes, indirectly. The medication itself does not damage skin, but the fast weight loss it drives can cause facial volume loss, skin laxity, dryness and a weakened moisture barrier. Dermatology reviews now describe these as common, manageable effects of GLP-1 weight loss.

Skin relies on collagen and elastin to retract as you slim down, but rapid loss outpaces that renewal, so skin can slacken before it adapts. The effect is usually greater with larger or faster weight loss and in more mature skin.

Topicals cannot replace lost facial fat, but they can soften the visible changes. Humectants like hyaluronic acid plump and hydrate, barrier lipids lock in moisture, and firming actives support elasticity. Starting early, while skin is still adapting, tends to give the best results. This is skincare guidance, not medical advice.

Four ingredients do most of the work: hyaluronic acid for deep hydration, ceramides with niacinamide to rebuild the skin barrier, firming actives to support collagen and elasticity, and squalane to restore a soft, healthy looking surface.

Often, yes. Lower food and fluid intake plus rapid metabolic change leave skin drier and can weaken its lipid barrier, raising transepidermal water loss (TEWL), which is felt as tightness, flaking and sensitivity. Replenishing ceramides has been shown to help restore the barrier.

The fat loss itself can be long lasting, but skin appearance often improves as weight stabilises and with consistent supportive care, and some people also consider in clinic volume treatments. Daily hydration, barrier repair and firming meaningfully improve day to day skin quality. Discuss medical options with your clinician.

As early as you can, ideally when you start treatment or notice the first signs of dryness or hollowing. Supporting hydration, barrier and firmness while skin is still adapting helps limit how visible the changes become.

References & citations

  1. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. doi.org/10.1056/NEJMoa2032183
  2. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. doi.org/10.1056/NEJMoa2206038
  3. Almandoz JP, Wadden TA, Tewksbury C, et al. Nutritional considerations with anti-obesity medications: practical clinical recommendations for the use of GLP-1 receptor agonists. Obesity (Silver Spring). 2022;30(8):1497-1512. doi.org/10.1002/oby.23517
  4. Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight (STEP 3). JAMA. 2021;325(14):1403-1413. doi.org/10.1001/jama.2021.1831
  5. Montecinos K, et al. Semaglutide face and implications in cosmetic dermatology. Dermatological Reviews. 2024. doi.org/10.1002/der2.70003
  6. Salam A, Hyder M. Semaglutide and the skin: dermatologic implications. CosmoDerma. 2025;5:84. doi.org/10.25259/CSDM_97_2025

This page is for education and does not replace medical advice. GLP-1 medicines are prescription-only and used under medical supervision. Always consult your doctor about your treatment.